These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12763518)

  • 1. Hormone therapy and venous thromboembolism.
    Peverill RE
    Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):149-64. PubMed ID: 12763518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormone replacement therapy and venous thromboembolism].
    Pavičić Baldani D; Skrgatić L; Simunić V; Elvedi Gasparović V; Geršak B
    Lijec Vjesn; 2015; 137(1-2):34-40. PubMed ID: 25906547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis.
    Scarabin PY
    Climacteric; 2018 Aug; 21(4):341-345. PubMed ID: 29570359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
    Eilertsen AL; Liestøl S; Mowinckel MC; Hemker HC; Sandset PM
    Thromb Haemost; 2007 Jun; 97(6):938-43. PubMed ID: 17549295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M
    Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].
    Caserta L; Caserta R; Torella M; Perricone F; Nesti E; Sessa M; Tagliaferri A; De Francesco F; De Lucia D; Panariello S
    Minerva Ginecol; 2004 Apr; 56(2):131-6. PubMed ID: 15258541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
    Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications for hormone replacement therapy].
    Birkhäuser MH
    Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and venous thromboembolism.
    Eisenberger A; Westhoff C
    J Steroid Biochem Mol Biol; 2014 Jul; 142():76-82. PubMed ID: 24007716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal hormone replacement therapy and venous thromboembolism.
    Wu O
    Gend Med; 2005; 2 Suppl A():S18-27. PubMed ID: 16551553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy.
    Lowe G; Woodward M; Vessey M; Rumley A; Gough P; Daly E
    Thromb Haemost; 2000 Apr; 83(4):530-5. PubMed ID: 10780311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormones and venous thromboembolism among postmenopausal women.
    Scarabin PY
    Climacteric; 2014 Dec; 17 Suppl 2():34-7. PubMed ID: 25223916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestogens and venous thromboembolism among postmenopausal women using hormone therapy.
    Canonico M; Plu-Bureau G; Scarabin PY
    Maturitas; 2011 Dec; 70(4):354-60. PubMed ID: 22024394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone therapy and venous thromboembolism among postmenopausal women.
    Scarabin PY
    Front Horm Res; 2014; 43():21-32. PubMed ID: 24943295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone therapy and thromboembolic disease.
    Battaglioli T; Martinelli I
    Curr Opin Hematol; 2007 Sep; 14(5):488-93. PubMed ID: 17934355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal hormone therapy and risk of venous thromboembolism: The story so far.
    Abdelhafez MMA; Ahmed KAM; Ahmed NAM; Ismail MH; Daud MNM; Eldiasty AME; Amri MFB; Jeffree MS; Masnah FK; Baharuddin DMP; Bolong MF; Hayati MF; Azizan NB; Sumpat D; Abdul Rahim SSS; Than WW; Ibrahim MY; Lo ZZ; Soe MZ
    Afr J Reprod Health; 2024 Mar; 28(3):122-129. PubMed ID: 38583076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
    Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
    Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.